share_log

金城医药:子公司药品注射用头孢噻肟钠获批

Shandong Jincheng Pharmaceutical Group: Subsidiary's injectable Cefotaxime Sodium has been approved.

Breakings ·  Apr 14 17:12

Shandong Jincheng Pharmaceutical Group announced that its holding subsidiary, Jincheng Jinsu, received the "Drug Supplement Application Approval Notification" issued by the National Medical Products Administration for injectable Cefotaxime Sodium. The approval notification includes specifications of 1.0g and 2.0g. Cefotaxime Sodium is a third-generation cephalosporin antibiotic characterized by high efficiency, broad spectrum, low toxicity, and enzyme resistance, suitable for infections caused by sensitive bacteria.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment